Comparison of remimazolam and volatile anesthetics on emergence agitation after general anesthesia

Comparison of remimazolam and volatile anesthetics on emergence agitation after general anesthesia for nasal surgery: A prospective randomized controlled study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0006528

Enrollment

Registered

2021-09-02

Start date

2021-11-03

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : In the remimazolam group, anesthesia is maintained by continuous intravenous infusion of remimazolam and remifentanil. In the inhalation anesthetic group, anesthesia is maintained using an inha

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective nasal surgery of otolaryngology under general anesthesia 2. Patients in class I and II according to the American Society of Anesthesiologists physical status classification 3. Age 19-65

Exclusion criteria

Exclusion criteria: - patients who are less than 19 years old, 66 years old or older -Emergency surgery -Hemodynamic instability or respiratory failure - In case of contraindications to the use of remimazolam (ex. hypersensitivity to benzodiazepine drugs, glaucoma, alcohol or drug dependence, sleep apnea syndrome, renal failure, liver failure, etc.) -psychiatric history and cognitive impairment

Design outcomes

Primary

Measure	Time frame
incidence rate of emergence agitation after general anesthesia	—

Secondary

Measure	Time frame
Severity of emergence agitation after general anesthesia	—

Countries

Korea, Republic of

Contacts

Public ContactSung-Ae Cho

Konyang University Hospital

sachosa@naver.com+82-42-600-9301

Outcome results